Ormidol (Atenolol)

Atenolol, the active ingredient in Ormidol, is a beta‑blocker presented as a tablet for oral use. It is used to manage cardiovascular conditions such as hypertension and angina, and to reduce the risk of further cardiac events in certain patient groups. GNH USA supplies Ormidol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ormidol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ormidol (atenolol) acts on the cardiovascular system to control blood pressure and heart workload.

- Hypertension: helps lower elevated blood pressure and maintain it within target ranges. - Angina pectoris: reduces the frequency and severity of chest pain episodes. - Post‑myocardial infarction: lowers the risk of recurrent heart attacks and improves long‑term survival. - Arrhythmias (certain types): assists in controlling heart rate and rhythm abnormalities. - Heart failure (mild to moderate): used as part of combination therapy to improve symptoms and outcomes.

Atenolol may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Fatigue - Dizziness - Cold extremities - Gastrointestinal discomfort - Sleep disturbances - Mild bradycardia

Serious or Rare Side Effects: - Severe bradycardia - Heart block - Hypotension - Bronchospasm in susceptible individuals - Worsening heart failure - Allergic reactions such as rash or angio‑edema

When using Ormidol, certain safety considerations should be observed.

- Cardiovascular assessment: evaluate heart function before initiating therapy. - Respiratory conditions: use cautiously in patients with asthma or chronic obstructive pulmonary disease. - Diabetes monitoring: monitor blood glucose as beta‑blockade may mask hypoglycaemia symptoms. - Pregnancy and lactation: avoid unless clearly needed; discuss risks with a healthcare professional. - Concomitant drugs: review all medications for potential interactions. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Atenolol can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Non‑selective beta‑blockers: combined use may cause excessive bradycardia. - Calcium channel blockers (verapamil, diltiazem): increased risk of heart block and hypotension. - Anti‑arrhythmic agents: additive effects on cardiac conduction.

Moderate Interactions (Monitor Closely): - Antidiabetic drugs: beta‑blockade may mask hypoglycaemia signs. - NSAIDs: may reduce antihypertensive effect. - Certain antidepressants (e.g., sertraline): may enhance bradycardic response.